The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Covidien Completes Acquisition of BÂRRX Medical, Inc.

Thursday, January 05, 2012

Covidien Completes Acquisition of BÂRRX Medical, Inc.16:00 EST Thursday, January 05, 2012 DUBLIN (Business Wire) -- Covidien plc (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of BÂRRX Medical, Inc., for an aggregate consideration of approximately $325 million, net of cash and short-term investments acquired. Pursuant to the terms of the acquisition agreement, Covidien will acquire all of the outstanding capital stock of BÂRRX, a private company, with additional future earn-out payments made upon achievement of certain milestones. “This is an exciting day for both Covidien and BÂRRX Medical,” said Bryan Hanson, Group President, Surgical Solutions, Covidien. “We are embarking on a promising future, with this acquisition providing a new growth platform for our business. We look forward to accelerating the growth of the HALO ablation technology product line and expanding it worldwide.” “Covidien offers many advantages to BÂRRX Medical that support our mission in long-term growth and value to patients,” said Greg Barrett, President and CEO, BÂRRX Medical. “Together we'll be able to leverage our core strengths to improve and develop new RF technologies.” About Covidien Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. For CovidienMarta Newhart, 303-530-2300, ext. 7383Vice President, Communications & Public AffairsSurgical Solutionsmarta.newhart@covidien.comorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor Relationscole.lannum@covidien.comorBruce Farmer, 508-452-4372Vice PresidentPublic Relationsbruce.farmer@covidien.comorTodd Carpenter, 508-452-4363DirectorInvestor Relationstodd.carpenter@covidien.com